BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15769620)

  • 21. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.
    Tsai LC; Beavo JA
    Curr Opin Pharmacol; 2011 Dec; 11(6):670-5. PubMed ID: 21962440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cGMP signal termination.
    Pyne NJ; Arshavsky V; Lochhead A
    Biochem Soc Trans; 1996 Nov; 24(4):1019-22. PubMed ID: 8968504
    [No Abstract]   [Full Text] [Related]  

  • 27. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
    Soderling SH; Bayuga SJ; Beavo JA
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 30. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hepatocyte growth factor on cyclic nucleotide-dependent signaling and steroidogenesis in rat ovarian granulosa cells in vitro.
    Zachow RJ; Woolery JK
    Biol Reprod; 2002 Aug; 67(2):454-9. PubMed ID: 12135881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic GMP and regulation of cyclic nucleotide hydrolysis.
    Sonnenburg WK; Beavo JA
    Adv Pharmacol; 1994; 26():87-114. PubMed ID: 8038108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
    J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation.
    Pelligrino DA; Wang Q
    Prog Neurobiol; 1998 Oct; 56(1):1-18. PubMed ID: 9723128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.